Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies

Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies

Bibliographic Details
Main Author:	Frontiers Editorial Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Immunology
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1285591/full

Similar Items

RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies
by: Navid Shomali, et al.
Published: (2022-03-01)

microRNAs regulate survivin in colorectal cancer patients
by: Hadi Chavoshi, et al.
Published: (2023-01-01)

MicroRNAs in Autoimmune Sjögren’s Syndrome
by: Seunghee Cha, et al.
Published: (2018-12-01)

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway
by: Frontiers Editorial Office
Published: (2023-10-01)

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
by: Mariano Catanesi, et al.
Published: (2020-08-01)

Retraction: Survivin knockdown alleviates pathological hydrostatic pressure-induced bladder smooth muscle cell dysfunction and BOO-induced bladder remodeling via autophagy
by: Frontiers Editorial Office
Published: (2023-08-01)

Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer
by: Po-Shuan Huang, et al.
Published: (2021-10-01)

The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer—An Update
by: Pui-Wah Choi, et al.
Published: (2022-06-01)

MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis
by: Fahimeh Ghasemi, et al.
Published: (2022-10-01)

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells
by: Lara Evers, et al.
Published: (2023-02-01)

An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease
by: Zahari Sham, Siti Yazmin, et al.
Published: (2022)

Retraction: PRDM16 upregulation induced by MicroRNA-448 inhibition alleviates atherosclerosis via the TGF-β signaling pathway inactivation
by: Frontiers Editorial Office
Published: (2023-10-01)

MicroRNAs and ‘Sponging’ Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets
by: Brian G. Jorgensen, et al.
Published: (2022-02-01)

Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
by: Nadine de Godoy Torso, et al.
Published: (2021-11-01)

Targeting microRNAs in obesity
by: Xie, Huangming, et al.
Published: (2012)

Data on microRNAs and microRNA-targeted mRNAs in Xenopus ectoderm
by: Vrutant V. Shah, et al.
Published: (2016-12-01)

Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study
by: Irma Karabegović, et al.
Published: (2023-07-01)

Retraction: Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor
by: Frontiers Editorial Office
Published: (2023-01-01)

Retraction: The role of LINC00284 in the development of thyroid cancer via its regulation of the microRNA-30d-5p-mediated ADAM12/Notch axis
by: Frontiers Editorial Office
Published: (2023-04-01)

Retraction: Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells
by: Frontiers Editorial Office
Published: (2023-07-01)

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer
by: Ying Yang, et al.
Published: (2022-12-01)

Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy
by: Adam Eckburg, et al.
Published: (2020-08-01)

MicroRNAs: Novel Targets in Hepatic Ischemia–Reperfusion Injury
by: Holly Ingram, et al.
Published: (2022-03-01)

MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity
by: Zacharias Fasoulakis, et al.
Published: (2023-09-01)

Targeting and function of mammalian microRNAs
by: Farh, Kyle Kai-How
Published: (2014)

Retraction: Longitude variation of the microRNA-497/FGF-23 axis during treatment and its linkage with neoadjuvant/adjuvant trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients
by: Frontiers Editorial Office
Published: (2023-10-01)

MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin
by: Ji-Young Yoo, et al.
Published: (2021-07-01)

Novel Codes of Psychiatry: MicroRNAs
by: Mehmet Akif Camkurt, et al.
Published: (2016-03-01)

microRNAs as Novel Therapeutics in Cancer
by: Giulia Romano, et al.
Published: (2021-03-01)

MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors
by: Valentina Angerilli, et al.
Published: (2021-03-01)

Traumatic brain injury dysregulates microRNAs to modulate cell signaling in rat hippocampus.
by: Liang Liu, et al.
Published: (2014-01-01)

Identification of novel microRNAs in <it>Hevea brasiliensis </it>and computational prediction of their targets
by: Gébelin Virginie, et al.
Published: (2012-02-01)

Most mammalian mRNAs are conserved targets of microRNAs
by: Friedman, Robin Carl, et al.
Published: (2011)

Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
by: Rebecca Raue, et al.
Published: (2021-02-01)

The Evolution of Imprinted microRNAs and Their RNA Targets
by: David Haig, et al.
Published: (2020-09-01)

MicroRNAs as Biomarkers and Therapeutic Targets for Medulloblastomas
by: O. A. Beylerli, et al.
Published: (2020-12-01)

MicroRNAs: Target Recognition and Regulatory Functions
by: Bartel, David
Published: (2015)

MicroRNAs in adipogenesis and as therapeutic targets for obesity
by: Alexander, Ryan, et al.
Published: (2014)

Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation
by: Carol Stella, et al.
Published: (2023-03-01)

Survivin as a Preferential Target for Cancer Therapy
by: Mahsa Mobahat, et al.
Published: (2014-02-01)